Cargando…

Target Values and Daytime Variation of Bone Turnover Markers in Monitoring Osteoporosis Treatment After Fractures

The serum bone turnover markers (BTM) procollagen type 1 N‐terminal propeptide (P1NP) and C‐terminal cross‐linking telopeptide of type 1 collagen (CTX) are recommended for monitoring adherence and response of antiresorptive drugs (ARD). BTM are elevated about 1 year after fracture and therefore BTM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borgen, Tove T, Solberg, Lene B, Lauritzen, Trine, Apalset, Ellen M, Bjørnerem, Åshild, Eriksen, Erik F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189911/ https://www.ncbi.nlm.nih.gov/pubmed/35720666 http://dx.doi.org/10.1002/jbm4.10633

Ejemplares similares

Effect of a Fracture Liaison Service on the Rate of Subsequent Fracture Among Patients With a Fragility Fracture in the Norwegian Capture the Fracture Initiative (NoFRACT): A Trial Protocol
por: Andreasen, Camilla, et al.
Publicado: (2018)

Increased cortical porosity and reduced cortical thickness of the proximal femur are associated with nonvertebral fracture independent of Fracture Risk Assessment Tool and Garvan estimates in postmenopausal women
por: Kral, Rita, et al.
Publicado: (2017)

Validation of forearm fracture diagnoses in administrative patient registers
por: Omsland, Tone Kristin, et al.
Publicado: (2023)

Determinants of trabecular bone score and prevalent vertebral fractures in women with fragility fractures: a cross-sectional sub-study of NoFRACT
por: Borgen, T.T., et al.
Publicado: (2019)

Associations of overweight, obesity and osteoporosis with ankle fractures
por: Hjelle, Anja M., et al.
Publicado: (2021)

Forearm fractures – are we counting them all? An attempt to identify and include the missing fractures treated in primary care
por: Dahl, Cecilie, et al.
Publicado: (2023)

No association between osteoporosis and AO classification of distal radius fractures: an observational study of 289 patients
por: Hjelle, Anja M., et al.
Publicado: (2020)

Bone turnover markers: Emerging tool in the management of osteoporosis
por: Shetty, Sahana, et al.
Publicado: (2016)

Clinical Application of Bone Turnover Markers in Osteoporosis in Korea
por: Park, So Young, et al.
Publicado: (2019)

Associations of LRP5 Gene With Bone Mineral Density, Bone Turnover Markers, and Fractures in the Elderly With Osteoporosis
por: Wang, Qi-Fei, et al.
Publicado: (2020)

Position Statement on the Use of Bone Turnover Markers for Osteoporosis Treatment
por: Park, So Young, et al.
Publicado: (2019)

Bone trait ranking in the population is not established during antenatal growth but is robustly established in the first postnatal year
por: Skåren, Lise, et al.
Publicado: (2018)

Use of Bone Turnover Markers in Clinical Practice for the Management of Osteoporosis in Korea: From the Survey on the Prescription Pattern of Bone Turnover Markers
por: Ahn, Seong Hee, et al.
Publicado: (2019)

Biochemical Bone Turnover Markers and Osteoporosis in Older Men: Where Are We?
por: Szulc, Pawel
Publicado: (2011)

Associations of IDUA and PTCH1 with Bone Mineral Density, Bone Turnover Markers, and Fractures in Chinese Elderly Patients with Osteoporosis
por: Wang, Qifei, et al.
Publicado: (2019)

Variation of Bone Turnover Markers in Childhood and Adolescence
por: Zhang, Yiduo, et al.
Publicado: (2023)

Current Recommendations for Laboratory Testing and Use of Bone Turnover Markers in Management of Osteoporosis
por: Lee, Jehoon, et al.
Publicado: (2012)

Airflow limitation as a risk factor for low bone mineral density and hip fracture: The Hordaland Health Study (HUSK) – 10 years follow-up of a general population
por: Herland, Trine, et al.
Publicado: (2016)

Effect of Denosumab on Bone Mineral Density and Markers of Bone Turnover among Postmenopausal Women with Osteoporosis
por: Sánchez, A., et al.
Publicado: (2016)

Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal women
por: Kharroubi, Akram, et al.
Publicado: (2017)

Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis
por: Mederle, Ovidiu Alexandru, et al.
Publicado: (2018)

Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis
por: Lorentzon, Mattias, et al.
Publicado: (2019)

Meta-analysis of the effects of denosumab and romosozumab on bone mineral density and turnover markers in patients with osteoporosis
por: Hu, Mingwei, et al.
Publicado: (2023)

Are the Relationships of Lean Mass and Fat Mass With Bone Microarchitecture Causal or Due to Familial Confounders? A Novel Study of Adult Female Twin Pairs
por: Bui, Minh, et al.
Publicado: (2020)

Impact of Total Hip Replacements on the Incidence of Hip Fractures in Norway During 1999–2019. A Norwegian Epidemiologic Osteoporosis Studies (NOREPOS) Study
por: Kjeldgaard, Helena Kames, et al.
Publicado: (2022)

The prevalence and treatment of osteoporosis in patients undergoing total hip arthroplasty and the levels of biochemical markers of bone turnover
por: Watanabe, Naoto, et al.
Publicado: (2022)

Reference markers of bone turnover for prediction of fracture: a meta-analysis
por: Tian, Aixian, et al.
Publicado: (2019)

Influence of Obesity on Bone Turnover Markers and Fracture Risk in Postmenopausal Women
por: López-Gómez, Juan J., et al.
Publicado: (2022)

Hypercholesterolaemia increases the risk of high-turnover osteoporosis in men
por: Zhou, Yanman, et al.
Publicado: (2019)

Bone turnover markers as surrogates of fracture healing after intramedullary fixation of tibia and femur fractures
por: Stewart, Christopher C., et al.
Publicado: (2022)

Teriparatide vs. Alendronate as a treatment for osteoporosis: Changes in biochemical markers of bone turnover, BMD and quality of life
por: Panico, Annalisa, et al.
Publicado: (2011)

Relationship Among Panoramic Radiography Findings, Biochemical Markers of Bone Turnover and Hip BMD in the Diagnosis of Postmenopausal Osteoporosis
por: Johari Khatoonabad, M., et al.
Publicado: (2011)

Real-world bone turnover marker use: impact on treatment decisions and fracture
por: Lane, N. E., et al.
Publicado: (2020)

Association between bone turnover markers and the risk of imminent recurrent osteoporotic fracture
por: Zhang, Bo, et al.
Publicado: (2022)

Daytime pattern of post-exercise protein intake affects whole-body protein turnover in resistance-trained males
por: Moore, Daniel R, et al.
Publicado: (2012)

External Validation of the Garvan Nomograms for Predicting Absolute Fracture Risk: The Tromsø Study
por: Ahmed, Luai A., et al.
Publicado: (2014)

Bone mass, bone markers and prevalence of fractures in adults with osteogenesis imperfecta
por: Wekre, Lena Lande, et al.
Publicado: (2011)

Positive predictive values of ICD-10 codes to identify incident acute pancreatitis and incident primary malignancy in the Scandinavian national patient registries among women with postmenopausal osteoporosis
por: Munch, Troels, et al.
Publicado: (2017)

Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis
por: Sugimoto, T., et al.
Publicado: (2013)

Vitamin D and Calcium in Osteoporosis, and the Role of Bone Turnover Markers: A Narrative Review of Recent Data from RCTs
por: Voulgaridou, Gavriela, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gk2aj1bu8usl2i0am2b16mhdtf